November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Experts Outline New Strategies to Overcome Barriers in Sarcopenia Drug Development

🥗 Nutrition 2 min read 👁 3

An expert working group has released updated recommendations to address the ongoing lack of approved pharmacological treatments for sarcopenia.

Experts Outline New Strategies to Overcome Barriers in Sarcopenia Drug Development🥗Nutrition

Photo: Nature Health Sciences

Key points

  • Sarcopenia involves a significant loss of muscle mass, strength, and overall physical function.
  • Despite rising clinical awareness, there are currently no approved pharmacological therapies specifically for the condition.
  • A new expert working group has published updated recommendations to harmonize clinical trial designs and regulatory standards.

Addressing the Gap in Sarcopenia Treatment

Sarcopenia, defined by a progressive decline in muscle mass, strength, and function, is frequently linked to adverse health events such as falls, fractures, and a higher risk of premature mortality. Despite a growing awareness of its widespread clinical and societal impact, researchers have yet to successfully translate scientific advancements into officially approved drug therapies. A working group convened by the World Health Organization Collaborating Centre for Epidemiology of Musculoskeletal Conditions and Ageing recently evaluated why progress remains slow.

According to the expert perspective published in Nature Health Sciences, the primary obstacles include inconsistencies in clinical trial designs, varying patient eligibility criteria, differing follow-up timelines, and a lack of regulatory harmonization across regions. Because medical definitions and trial methodologies have evolved since the previous guidelines established in 2020 by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), experts set out to redefine standard approaches for upcoming therapeutic evaluations.

What to Know About Trial Design and Future Care

The newly outlined framework details modern strategies for conducting pharmacological trials targeting age-related muscle loss. This guidance covers how to properly select target populations, incorporate digital health metrics, utilize patient-reported outcomes, and implement reliable biomarkers. As clinical researchers work to standardize these assessments, patients are always advised to consult a qualified healthcare provider for personal medical guidance, diagnosis, or treatment decisions regarding physical decline and nutrition.

Source Nature Health Sciences — nature.com/articles/s41584-026-01457-4 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.